Complement Receptor 1 and 2 Deficiency Increases Coxsackievirus B3-Induced Myocarditis, Dilated Cardiomyopathy, and Heart Failure by Increasing Macrophages, IL-1β, and Immune Complex Deposition in the Heart1
暂无分享,去创建一个
Ziya Kaya | Noel R. Rose | N. Rose | Sarah E. Davis | Z. Kaya | D. Fairweather | Sylvia Frisancho-Kiss | D. Njoku | DeLisa Fairweather | Sylvia Frisancho-Kiss | Dolores B. Njoku | Jennifer F. Nyland | Susy A. Yusung | J. Augusto Frisancho | Masheka A. Barrett | J. Nyland | J. Frisancho
[1] V. M. Holers,et al. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice. , 1997, Journal of immunology.
[2] N. Rose,et al. Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus‐induced myocarditis , 2005, Reviews in medical virology.
[3] Ziya Kaya,et al. Complement receptors regulate lipopolysaccharide‐induced T‐cell stimulation , 2005, Immunology.
[4] P. Portolés,et al. Crry/p65, a Membrane Complement Regulatory Protein, Has Costimulatory Properties on Mouse T Cells1 , 2000, The Journal of Immunology.
[5] G. W. Dec,et al. Introduction to Clinical Myocarditis , 2003 .
[6] K. Baughman,et al. Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. , 1990, Journal of the American College of Cardiology.
[7] D. Fairweather,et al. Characterisation of murine cytomegalovirus myocarditis: cellular infiltration of the heart and virus persistence. , 2002, Journal of molecular and cellular cardiology.
[8] G. Peltz,et al. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma , 2000, Nature Immunology.
[9] S. Marsch,et al. Interleukin-6–Deficient Mice Resist Development of Autoimmune Myocarditis Associated With Impaired Upregulation of Complement C3 , 2003, Circulation.
[10] J. Prechl,et al. Complement Receptor Type 1 (CD35) Mediates Inhibitory Signals in Human B Lymphocytes1 , 2002, The Journal of Immunology.
[11] N. Rose,et al. Interferon- Protects against Chronic Viral Myocarditis by Reducing Mast Cell Degranulation, Fibrosis, and the Profibrotic Cytokines Transforming Growth Factor- 1, Interleukin-1 , and Interleukin-4 in the Heart , 2004 .
[12] M. Weigert,et al. Autoreactive B Cells in the Marginal Zone that Express Dual Receptors , 2002, The Journal of experimental medicine.
[13] J. Hosenpud,et al. Interleukin-1-induced myocardial depression in an isolated beating heart preparation. , 1989, The Journal of heart transplantation.
[14] V. Holers,et al. Complement receptors and the shaping of the natural antibody repertoire , 2005, Springer Seminars in Immunopathology.
[15] Ziya Kaya,et al. Contribution of the innate immune system to autoimmune myocarditis: a role for complement , 2001, Nature Immunology.
[16] A. Herskowitz,et al. Interleukin 1 or tumor necrosis factor can promote Coxsackie B3-induced myocarditis in resistant B10.A mice , 1992, The Journal of experimental medicine.
[17] J. Kearney,et al. Marginal zone B cells in lymphocyte activation and regulation. , 2005, Current opinion in immunology.
[18] Wen-chao Song,et al. Membrane complement regulatory proteins in autoimmune and inflammatory tissue injury. , 2004, Current directions in autoimmunity.
[19] M. Carroll,et al. The complement system in B cell regulation. , 2004, Molecular immunology.
[20] N. Rose,et al. From infection to autoimmunity. , 2001, Journal of autoimmunity.
[21] K. Ley,et al. L-Selectin, α4β1, and α4β7 Integrins Participate in CD4+ T Cell Recruitment to Chronically Inflamed Small Intestine1 , 2005, The Journal of Immunology.
[22] N. Rose,et al. Mast Cells and Innate Cytokines are Associated with Susceptibility to Autoimmune Heart Disease Following Coxsackievirus B3 Infection , 2004, Autoimmunity.
[23] N. Rose. Mechanisms of Autoimmunity , 2002, Seminars in liver disease.
[24] N. Rose,et al. Inflammatory heart disease: a role for cytokines , 2005, Lupus.
[25] P. Butko,et al. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[26] P. Lodge,et al. Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice. , 1986, The American journal of pathology.
[27] R. Karr,et al. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[28] J. Ahearn,et al. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. , 1996, Immunity.
[29] A. Herskowitz,et al. Induction of multiple heart autoantibodies in mice with coxsackievirus B3- and cardiac myosin-induced autoimmune myocarditis. , 1994, Journal of immunology.
[30] Christopher C. Goodnow,et al. C3d of Complement as a Molecular Adjuvant: Bridging Innate and Acquired Immunity , 1996, Science.
[31] S. Christensen,et al. The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. , 1990, Journal of immunology.
[32] D. Kass,et al. Novel Model of Constrictive Pericarditis Associated With Autoimmune Heart Disease in Interferon-γ–Knockout Mice , 2004, Circulation.
[33] J. E. Barbosa,et al. Reduced erythrocyte complement receptor type 1 in systemic lupus erythematosus is related to a disease activity index and not to the presence or severity of renal disease , 2004, Lupus.
[34] V. Hombach,et al. Complement and dilated cardiomyopathy: a role of sublytic terminal complement complex-induced tumor necrosis factor-alpha synthesis in cardiac myocytes. , 2002, The American journal of pathology.
[35] P. Schur,et al. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus. , 1986, Arthritis and rheumatism.
[36] M. Shi,et al. Acquired but reversible loss of erythrocyte complement receptor 1 (CR1, CD35) and its longitudinal alteration in patients with severe acute respiratory syndrome , 2005, Clinical and experimental immunology.
[37] Ryozo Nagai,et al. Gene Expression in Fibroblasts and Fibrosis: Involvement in Cardiac Hypertrophy , 2002, Circulation research.
[38] Michael J. Zilliox,et al. Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. , 2001, The American journal of pathology.
[39] P. Allen,et al. Myosin-induced acute myocarditis is a T cell-mediated disease. , 1991, Journal of immunology.
[40] S. Krishnaswami,et al. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. , 2004, Arthritis and rheumatism.
[41] B. McManus,et al. Complement component 3 interactions with coxsackievirus B3 capsid proteins: innate immunity and the rapid formation of splenic antiviral germinal centers , 1997, Journal of virology.
[42] P. Anthony. Robbins' Pathologic Basis of Disease , 1990 .
[43] R. Corley,et al. Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells. , 2004, International immunology.
[44] B. Strauer,et al. Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. , 2000, Journal of the American College of Cardiology.
[45] E. Fisman,et al. Sudden unexpected death in persons less than 40 years of age. , 1991, The American journal of cardiology.
[46] R. Zinkernagel,et al. Protective T Cell–Independent Antiviral Antibody Responses Are Dependent on Complement , 1999, The Journal of experimental medicine.
[47] E. Fisman,et al. Sudden unexpected death in persons <40 years of age , 1991 .
[48] P. Lachmann,et al. Complement and immunity to viruses , 1997, Immunological reviews.
[49] P. Gasque. Complement: a unique innate immune sensor for danger signals. , 2004, Molecular immunology.
[50] N. Rose,et al. IL-12 Protects against Coxsackievirus B3-Induced Myocarditis by Increasing IFN-γ and Macrophage and Neutrophil Populations in the Heart1 , 2005, The Journal of Immunology.
[51] N. Rose,et al. Models of coxsackievirus-B3-induced myocarditis: recent advances , 2004 .
[52] D. Kass,et al. Impaired up-regulation of CD25 on CD4+ T cells in IFN-gamma knockout mice is associated with progression of myocarditis to heart failure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[53] John D Lambris,et al. Complement Component 3 Is Required for Optimal Expansion of CD8 T Cells During a Systemic Viral Infection1 , 2003, The Journal of Immunology.
[54] B. Winston,et al. Complement Factor B Gene Regulation: Synergistic Effects of TNF-α and IFN-γ in Macrophages1 , 2002, The Journal of Immunology.
[55] N. Rose,et al. IL-12 Receptor β1 and Toll-Like Receptor 4 Increase IL-1β- and IL-18-Associated Myocarditis and Coxsackievirus Replication1 , 2003, The Journal of Immunology.
[56] B. Morgan,et al. Complement Regulatory Proteins , 1999 .
[57] T. Miller,et al. Cardiac involvement in systemic lupus erythematosus. , 1999, Mayo Clinic proceedings.
[58] H. Kirchner,et al. Antigen localization within the splenic marginal zone restores humoral immune response and IgG class switch in complement C4-deficient mice. , 2004, International immunology.